Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...
TipRanks on MSN
BMY and BNTX advance new immunotherapy bet in first-line liver cancer with ROSETTA HCC-206
Biontech Se Sponsored Adr (BNTX), Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study.
Medical Device Network on MSN
Helio Genomics and LiverRight team up for early detection of liver cancer
LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.
Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy ...
Embolization is a safe, noninvasive treatment option for liver cancer tumors that can’t be removed surgically. You can usually go home on the same day as an embolization procedure, and side effects ...
An experimental vaccine has saved lives in an early clinical trial for a rare form of liver cancer that primarily affects younger patients, researchers with Johns Hopkins Kimmel Cancer Center ...
News-Medical.Net on MSN
Scientists unravel how citrin deficiency can trigger fat buildup in the liver even in lean individuals
Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ...
Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...
MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...
Scientists at City of Hope have unraveled how citrin deficiency (CD), a rare genetic disorder that prevents the liver from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results